| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b907c97ecc5bd1da35b945a97317c387 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00359
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-28 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3608 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 |
| filingDate |
2017-06-14^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-01-26^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f73959628c9f5b5fb920f475882c4e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f483ed42c9d9c0384f9adf550a62b2b1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cecd2da1e7a4d150d006a17da62a5af
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b3e0965a6e83acf532ffde3dfc7db5cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca26b5399e84f6b8e4d532bc4af7df9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c9479019d045c04e077ff5e787501a |
| publicationDate |
2021-01-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10898611-B2 |
| titleOfInvention |
Cancellous bone product including viable osteogenic cells |
| abstract |
A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least one loosening agent, such as collagenase or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying out their osteogenic function and to provide for an increased rate of bone formation. Such implant also may include demineralized bone, such as demineralized cortical bone, which enhances the bone regenerative capacity of the cancellous bone. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11471560-B2 |
| priorityDate |
2006-05-08^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |